Clinical Associated Group in Pharmacy

Associated Clinical Group

Implementation of a new therapeutical drug monitoring system in a clinical analytical laboratory for pharmacokinetic control of antibiotic, antifungal and antineoplastic agents in the hospitalized patient, with the aim of optimal and rational use of pharmacological treatment

Observational Study of population pharmacokinetic model of voriconazole in allogeneic stem cell transplantation. Study approved by the Agencia Española del medicamento y Productos Sanitarios with code CSV-VOR-2014-01

Study of Physico-chemical stability of a new mycophenolate mofetil intravenous solution in polypropilene infusion bag at different storage conditions

Study of pharmacokinetics of caspofungin in patients under hemodiafiltration. Study approved by the Agencia Española del Medicamento y Productos Sanitarios with code MER-CAS-2013-01

Study of pharmacokinetics of Ceftolozane in critical patients. Study pending of approval by the Agencia Española del Medicamento y Productos Sanitarios with code CEFT-TCRR-2017

Study of Physico-chemical stability of a new ophthalmic eyedrop formulation at different storage conditions

Dr. Manuel Alós Almiñana
Coordinator
Dr. Manuel Alós Almiñana
alos_man@gva.es; manuel.alos@uv.es

RESEARCHERS
Leading, R4

Manuel Alós Almiñana    

Established, R3

Teresa Torrecilla Junyent

Recognised/Emerging, R2

Carmen Carrión Carrión
Francisco Ferriols Lisart
Rafael Ferriols Lisart

First Stage, R1
STAFF
Collaborating Researchers

Carlos Ezquer Garín
Diego Cano Blanquer
Eva Del Río Losada
José Enrique Muñoz Cebriá
Mercedes Jiménez Heredia
Raquel Pardillo Armuña
Verónica Guillot Yacyszyn

Nurse

Elena Molina Quesada
María José Colubi Martínez

Technicians

Bárbara Muñoz Ponce
Mar Mallea Durbán
Raúl Torrejón Bastante

Administrative assistant
Publications
Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patients. Garcia-Molina A, Alos-Alminana M. Farmacia Hospitalaria. 2023 Jan-Feb;47(1):10-15. doi: 10.1016/j.farma.2022.12.003. PMID: 36635189

Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patients. Garcia-Molina A, Alos-Alminana M. Farmacia Hospitalaria. 2023 Jan-Feb;47(1):T10-T15. doi: 10.1016/j.farma.2022.12.014. PMID: 36707309

Validated HPLC-UV method for amphotericin B quantification in a critical patient receiving AmBisome and treated with extracorporeal replacement therapies. Ezquer-Garin C, Aguilar G, Ferriols-Lisart R, Alos-Alminana M. Biomedical Chromatography. 2023 Dec;37(12):e5749. doi: 10.1002/bmc.5749. PMID: 37727118

The usefulness of in vitro percutaneous absorption experiments applying the infinite dose technique to predict in vivo plasma levels: comparison of model-predicted and observed plasma concentrations of nortriptyline in rats. Usach I, Di Marco S, Diez O, Alos M, Peris J. Pharmaceutics. 2022 Jul 12;14(7):1457. doi: 10.3390/pharmaceutics14071457. PMID: 35890351

Effect of one-year dextromethorphan/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis. Sancho J, Ferrer S, Bures E, Diaz JL, Torrecilla T, Signes-Costa J, Servera E. Respiratory Medicine. 2021 Jul 7;186:106536. doi: 10.1016/j.rmed.2021.106536. PMID: 34260979

Health outcomes and primary adherence to secondary prevention treatment after st-elevation myocardial infarction: a spanish cohort study. Lopez A, Alos Almiñana M, Peris J. Journal of Cardiovascular Translational Research. 2021 Apr;14(2):308-316. doi: 10.1007/s12265-020-10045-0. PMID: 32557320

+ Info
Title: Desarrollo y validación de métodos cromatográficos ajustados a propósito para la monitorización de antimicrobianos de interés clínico. Aplicación a estudios farmacocinéticos
Doctoral candidate: Ezquer Garin, Carlos
Director(s): Medina Hernández, María José; Escuder Gilabert, Laura
Date of the defense: 03/03/2023
University: University de Valencia

Title: Evaluaciónn económica en la práctica asistencial del tratamiento del virus de la hepatitis c basado en antivirales de acción directa
Doctoral candidate: Pardillo Armuña, Raquel
Director(s): Alós Almiñana, Manuel; D’ocon Navaza, Pilar; Ferriols Lisart, Rafael
Date of the defense: 21/11/2022
University: Universitat de València